Cytokine Plasma Levels as Predictors for Radiation Pneumonitis in Lung Cancer
Author Information
Author(s): Rübe Claudia E., Palm Jan, Erren Michael, Fleckenstein Jochen, König Jochem, Remberger Klaus, Rübe Christian
Primary Institution: Saarland University
Hypothesis
Can cytokine plasma levels predict the risk of radiation pneumonitis in patients with non-small-cell lung cancer?
Conclusion
Cytokine plasma levels do not reliably identify patients at risk for radiation pneumonitis, as they are influenced more by tumor-derived production than by radiation effects.
Supporting Evidence
- 21 out of 52 patients developed radiation pneumonitis.
- Cytokine levels did not correlate with the incidence of radiation pneumonitis.
- IL-6 and TGF-β1 levels were elevated before treatment in most patients.
- Significant correlations were found between cytokine levels and tumor responses.
Takeaway
The study looked at whether certain proteins in the blood could help predict if lung cancer patients would have problems after radiation treatment, but it found that these proteins are mostly coming from the tumors themselves.
Methodology
Cytokine plasma levels were measured in patients before, during, and after radiotherapy, and correlated with the incidence of radiation pneumonitis and tumor responses.
Potential Biases
Potential bias due to the influence of tumor-derived cytokine production on plasma levels.
Limitations
The study's sample size was small, limiting the ability to perform valid subgroup analyses.
Participant Demographics
{"median_age":65.1,"gender_distribution":{"male":41,"female":11},"clinical_stage":{"stage_I":5,"stage_II":7,"stage_III":39}}
Statistical Information
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website